Novartis to swallow German cancer-drug maker
Swiss pharmaceutical giant Novartis said this week it had agreed to buy German biotech firm MorphoSys for 2.7 billion euros ($2.9 billion), giving it access to a new blood cancer treatment.
Feb 6, 2024
0
0